GO
Loading...

SGEN's Adcetris Targets Lymphomas

Tuesday, 10 Jan 2012 | 5:34 PM ET

Clay Siegall, Seattle Genetics president & CEO, discusses the company's cancer drug, Adcetris, and which new drugs are in the company's pipeline for 2012.